All conditions
BPC-157 for gut

Crohn's disease

Of the 2 unique stories with a clear outcome, 2 reported it helped (100%).

These are public YouTube testimonials, not clinical evidence. People who tried BPC-157 and got no result rarely post videos — read this as a sample of the positive end of the distribution.

Verdict
100
% positive
2 helped0 partial0 no help
What people tried
KPV peptide
Quote at 0:34
Helped · completeKPV peptideover 12 weeks
healed their gut in about three months
Quote at 8:10Tap to play
Helped · significantThin evidence
it can be magical for Crohn's and colitis
What the science says

Related research

All papers →
Review· ratmedium
2016

Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.

This review concludes that BPC-157, a gastric peptide, may serve as a remedy in various CNS-disorders and has shown beneficial effects in treating GI tract lesions, periodontitis, and liver and pancreas lesions. BPC-157 also has neuroprotective effects and modulates serotonergic and dopaminergic systems.

Current neuropharmacology· Sikiric P, Seiwerth S et al.
PubMed · PMID 27138887
Review· nulllow
2025

Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.

This review summarizes the biological activities of BPC 157, a peptide with potential therapeutic benefits for various medical conditions, including tissue injury and inflammatory bowel disease. The review highlights the need for comprehensive clinical studies to confirm its health benefits in humans.

Pharmaceuticals (Basel, Switzerland)· Józwiak M, Bauer M et al.
PubMed · PMID 40005999
Review· nulllow
2013

Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157.

This review suggests that BPC-157 may be used as an antidote against NSAIDs due to its beneficial effects on stomach, duodenum, intestine, liver, and brain injuries. BPC-157 has a high safety profile with no reported toxicity.

Current pharmaceutical design· Sikiric P, Seiwerth S et al.
PubMed · PMID 22950504
Review· ratlow
2010

Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator.

This review discusses the potential role of BPC-157 in cytoprotection and adaptive cytoprotection, suggesting it may be an essential mediator for stomach and gastrointestinal tract defense, with implications for wound healing. The review highlights BPC-157's safety and efficacy in clinical trials for inflammatory bowel disease and wound healing.

Current pharmaceutical design· Sikiric P, Seiwerth S et al.
PubMed · PMID 20166993